Dr. Parteek Prasher

Dr. Parteek Prasher's research focuses on developing multitargeting agents to manage adenocarcinoma pathogenesis, particularly in pancreatic, prostate, and breast cancers. His work aims to offer pharmaceutical alternatives to improve prognoses and reduce reliance on invasive treatments like prostatectomy.